Skip to main content
SpringerLink
Log in

Additivities of Compounds that Increase the Numbers of High Affinity [3H]Muscimol Binding Sites by Different Amounts Define More than 9 GABAA Receptor Complexes in Rat Forebrain: Implications for Schizophrenia and Clozapine Research

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Background

The numbers of [3H]MUS binding sites were reported to be elevated in layers II and III, but not V or VI, in cingulate cortex of schizophrenic brains post mortem. These increases in [3H]MUS binding sites are probably due to compensatory up-regulation of GABAA receptors on pyramidal cells as a consequence of a selective loss of GABAergic interneurons in layer II of cingulate cortex. The number of [3H]flunitrazepam binding sites was reported to be reduced in schizophrenic cingulate cortex, and this may directly reflect the loss of GABAergic interneurons. Chronic administration of clozapine to rats was reported to significantly reduce the numbers of [3H]MUS binding sites in temporal cortex and hippocampus which may be due to selective blockade of GABAA receptors on GABAergic interneurons that make synaptic contact with pyramidal cells. Basket cells are GABAergic interneurons that make synaptic contact with pyramidal cells as well as other interneurons. Basket cells can also generate both theta and gamma oscillations. Clozapine increases the power of theta and gamma EEG. Schizophrenic patients show reduced EEG power at 40 Hz (gamma frequency) but not at lower frequencies during auditory stimulation. The GABAA receptor blocker bicuculline at 10 nM, but not 10 μM, was reported to increase the amplitude of slow oscillations (≤1 Hz) in rat hippocampal slices. It therefore seems possible that clozapine, by selectively blocking another GABAA receptor, could increase the amplitude of gamma oscillations.

Findings

Twenty-six compounds that inhibit [35S]TBPS binding in ways that are reversible by 10 nM R-5135 were found to increase [3H]MUS binding to membranes prepared from rat whole forebrain. In almost all cases the increases in binding were due to increases in the number of binding sites with little effect on affinity (Kd) for [3H]MUS. Concentration-response curves for the compounds revealed maximum increases in [3H]MUS (Esat) binding ranging from 140% (for meclizine) to 313% of control for honokiol. Additivity experiments showed that propofol (44% above control) and diflunisal (50% above control) were almost entirely additive, but there was also a small, but significant overlap, suggesting the existence of three groups of [3H]MUS binding sites defined by propofol and diflunisal. Meclizine was entirely additive with both propofol and diflunisal, indicating the existence of a fourth [3H]MUS binding site. Alphaxalone is also completely additive with meclizine, and has an Esat value significantly larger than that for propofol + diflunisal suggesting a fifth [3H]MUS binding site. The Esat for mefenamate is significantly greater than the Esat for alphaxalone, and mefenamate is also completely additive with meclizine, suggesting the existence of a sixth [3H]MUS binding site. The Esat for magnolol is significantly greater then the Esat for mefenamate, and the Esat for honokiol is greater than that for magnolol, suggesting, but not proving, the existence of a seventh and an eighth group of [3H]MUS binding sites. The binding of [3H]MUS alone, without enhancers may represent a ninth group of binding sites which is probably heterogeneous as indicated by the very low pseudo Hill coefficients for bicuculline and strychnine in displacing [3H]MUS without enhancer. Altogether, our results suggest the existence of more than 9 different [3H]MUS binding sites. Clozapine was a very weak overall displacer of [3H]MUS (IC50 = 280 μM). However, 5 μM clozapine reduced [3H]MUS binding 6% (P < 0.0001, n = 10) and significantly reduced [3H]MUS binding enhanced by propofol (∼14%) or clotrimazole (∼17%) but not 17 other compounds tested.

Tentative conclusions

In the absence of enhancers [3H]MUS may bind preferentially to GABAA receptors on pyramidal cells and less to interneurons in cerebral cortex. Conversely, [3H]flunitrazepam may bind preferentially to GABAA receptors (allosterically) on interneurons and less to pyramidal cells. Clozapine appears to selectively block a small fraction (10–20%) of [3H]MUS binding sites with an IC50 value in the low micromolar range. This fraction may be preferentially located on certain GABAergic interneurons (basket cells?) that make synaptic contact with pyramidal cells. The blockade of these GABAA receptors by clozapine would be expected to increase the firing rate of the interneurons and the release of GABA onto pyramidal cells. Such blockade would also increase the generation of gamma oscillations by the basket cells. Some of these interneurons appear to be destroyed selectively, probably during the second trimester of gestation by a non-paralytic polio virus, in individuals who will later become schizophrenic. Since basket cells can generate gamma oscillations, the destruction of basket cells would reduce overall gamma power, which is observed in schizophrenics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Squires, R. F., Ai, J., Witt M-R., Kahnberg, P., Saederup, E. Sterner, O., and Nielsen, M. 1999. Honokiol and magnolol increase the number of [3H]muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites. Neurochem. Res. 24:1593–1602.

    Google Scholar 

  2. Olsen, R. W. and Snowman, A. M. 1982. Chloride-dependent enhancement by barbiturates of γ-aminobutyric acid receptor binding. J. Neurosci. 2:1812–1823.

    Google Scholar 

  3. Asano, T. and Ogasawara, N. 1981. Chloride-dependent stimulation of GABA and benzodiazepine receptor binding by pentobarbital. Brain Res. 225:212–216.

    Google Scholar 

  4. Peters, J. A., Kirkness, E. F., Callachan, H., Lambert, J. J., and Turner, A. J. 1988. Modulation of GABAA receptor by depressant barbiturates and pregnane steroids. Brit. J. Pharmacol. 94:1257–1269.

    Google Scholar 

  5. Kirkness, E. F. and Turner, A. J. 1986. The γ-aminobutyrate/ benzodiazepine receptor from pig brain, enhancement of γ-aminobutyrate-receptor binding by the anaesthetic propanidid. Biochem. J. 233:259–264.

    Google Scholar 

  6. Goodnough, D. B. and Hawkinson, J. E. 1995. Neuroactive steroid modulation of [3H]muscimol binding to the GABAA receptor complex in rat cortex. Eur. J. Pharmacol. Mol. Ph. 288:157–162.

    Google Scholar 

  7. Jussofie, A., Schmiz, A., and Hiemke, C. 1994. Kavapyrone enriched extract from piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacol. 116:469–474.

    Google Scholar 

  8. Witt, M-R and Nielsen, M. 1994. Characterization of the influence of unsaturated free fatty acids on brain GABA/ benzodiazepine receptor binding in vitro. J. Neurochem. 62: 1432–1439.

    Google Scholar 

  9. Koenig, J. A. and Martin, I. L. 1992. Effect of free fatty acids on GABAA receptor ligand binding. Biochem. Pharmacol. 44:11–15.

    Google Scholar 

  10. Wong, D. T., Rathbun, R. C., Bymaster, F. P., and Lacefield, W. B. 1983. Enhanced binding of radioligands to receptors of γ-aminobutyric acid and benzodiazepine by a new anticonvulsive agent LY81067. Life Sci. 33:917–923.

    Google Scholar 

  11. Bonnert, T. P., McKernan, R. M., Farrar, S., le Bourdellè s, B., Heavens, R. P., Smith, D. W., Hewson, L., Rigby, M. R., Sirinathsinghji, D. J. S., Brown, N., Wafford, K. A., and Whiting, P. J. 1999. θ, a novel γ-aminobutyric acid type A receptor subunit. Proc. Natl. Acad. Sci. 96:9891–9896.

    Google Scholar 

  12. Chang, Y., Wang, R., Barot, S., and Weiss, D. S. 1996. Stoichiometry of a recombinant GABAA receptor. J. Neurosci. 16:5415–5424.

    Google Scholar 

  13. Tretter, V., Ehya, N., Fuchs, K., and Sieghart, W. 1997. Stoichiometry and assembly of a recombinant GABAA receptor subtype. J. Neurosci. 17:2728–2737.

    Google Scholar 

  14. Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R., and Seeburg, P. H. 1989. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338:582–585.

    Google Scholar 

  15. Gü nther, U., Benson, J., Benke, D., Fritschy, J-M., Reyes, G., Knoflach, F., Crestani, F., Aguzzi, A., Arigoni, M., Lang, Y., Bluethmann, H., Mohler, H., and Lü scher, B. 1995. Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. 92:7749–7753.

    Google Scholar 

  16. Fritschy, J.-M. and Mohler, H. 1995. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:154–194.

    Google Scholar 

  17. Squires, R. F., Casida, J. E., Richardson, M., and Saederup, E. 1983. [35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol. Pharmacol. 23:326–336.

    Google Scholar 

  18. Benes, F. M., McSparren, J., Bird, E. D., SanGiovanni, J. P., and Vincent, S. L. 1991 Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48:996–1001.

    Google Scholar 

  19. Benes, F. M., Vincent, S. L., Alsterberg, G., Bird, E. D., and SanGiovanni, J. P. 1992. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12:924–929.

    Google Scholar 

  20. Benes, F. M. 1998. Model generation and testing to probe neural circuitry in cingulate cortex of postmortem schizophrenic brain. Schizophrenia Bull. 24:219–230.

    Google Scholar 

  21. Squires, R. F., Lajtha, A., Saederup, E., and Palkovits, M. 1993. Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses? Neurochem. Res. 18:219–223.

    Google Scholar 

  22. Benke, D., Fritschy, J.-M., Trzeciak, A., Bannwarth, W., and Mohler, H. 1994. Distribution, prevalence, and drug binding profile of γ-aminobutyric acid type A receptor subtypes differing in the γ-subunit variant. J. Biol. Chem. 269:27100–27107.

    Google Scholar 

  23. Gao, B. and Fritschy, J. M. 1994. Selective allocation of GABAA receptors containing the α1 subunit to neurochemically distinct subpopulations of rat hippocampal interneurons. Eur. J. Neurosci. 6:837–853.

    Google Scholar 

  24. Kwon, J. S., O'Donnell, B. F., Wallenstein, G. V., Greene, R. W., Hirayasu, Y., Nestor, P. G., Hasselmo, M. E., Potts, G. F., Shenton, M. E., and McCarley, R. W. 1999. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch. Gen. Psychiatry 56:1001–1005.

    Google Scholar 

  25. Traub, R. D., Jefferys, J. G. R., and Whittington, M. A. (1999). Fast Oscillations in Corical Circuits. The MIT Press, Cambridge, Massachusetts, London, England.

    Google Scholar 

  26. Zhang, Y., Velazquez, J. L. P., Tian, G. F., Wu, C.-P., Skinner, F. K., Carlen, P. L., and Zhang, L. 1998. Slow oscillations (≤1 Hz) mediated by GABAergic interneuronal networks in rat hippocampus. J. Neurosci. 18:9256–9268.

    Google Scholar 

  27. Skinner, F. K., Zhang, L., Velazquez, J. L. P., and Carlen, P. L. 1999. Bursting in inhibitory interneuronal networks: a role for gap-junctional coupling. J. Neurophysiol. 81:1274–1283.

    Google Scholar 

  28. Stille, G., Lauener, H., and Eichenberger, E. 1971. The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e] [1,4]diazepine (clozapine). Il Farmaco. 26:603–625.

    Google Scholar 

  29. Roubicek, J. and Major, I. 1977. EEG profile and behavioral changes after a single dose of cloazpine in normals and schizophrenics. Biol. Psychiatry 12:613–633.

    Google Scholar 

  30. Fink, M., Irwin, P., and Weinhold, P. 1979. EEG profile studies of clozapine in voluteers and psychiatric patients. Pharmakopsychiat. 12:184–190.

    Google Scholar 

  31. Squires, R. F. and Saederup, E. 1999. Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors. Neurochem. Res. 24:659–667.

    Google Scholar 

  32. Squires, R. F. and Saederup, E. 1998. Clozapine and several other antipsychotic/antidepressant drugs preferentially block the same 'core' fraction of GABAA receptors. Neurochem. Res. 23:1283–1290.

    Google Scholar 

  33. Wong, D. T., Threlkeld, P. G., Bymaster, F. P., and Squires, R. F. 1984. Saturable binding of 35S-t-butylbicyclophosphorothionate to the sites linked to the GABA receptor and the interaction with GABAergic agents. Life Sci. 34:853–860.

    Google Scholar 

  34. Placheta, P. and Karobath, M. 1980. In vitro modulation by SQ 20009 and SQ 65396 of GABA receptor binding in rat CNS membranes. Eur. J. Pharmacol. 62:225–228.

    Google Scholar 

  35. Ennis, C. and Minchin, M. C. W. 1993. Modulation of the GABAA-like autoreceptor by barbiturates but not by steroids. Neuropharmcol. 32:355–357.

    Google Scholar 

  36. Prince, R. J. and Simmonds, M. A. 1993. Differential antagonism by epipregnanolone of alphaxalone and pregnanolone potentiation of [3H]flunitrazepam binding suggests more than one class of binding site for steroids at GABAA receptors. Neurorpharmacol. 32:59–63.

    Google Scholar 

  37. Woodward, R. M., Polenzani, L., and Miledi, R. 1994. Effects of fenamates and other nonsteroidal anti-inflammatory drugs on rat brain GABAA receptors expressed in xenopus oocytes. J. Pharmacol. Exp. Ther. 268:806–817.

    Google Scholar 

  38. Halliwell, R. F., Thomas, P., Patten, D., James, C. H., Martinez-Torres, A. Miledi, R., and Smart, T. G. 1999. Subunit-selective modulation of GABAA receptors by the non-steriodal antiinflamatory agent, mefenamic acid. Eur. J. Neurosci. 11:2897–2905.

    Google Scholar 

  39. Concas, A., Santoro, G., Serra, M., Sanna, E., and Biggio, G. 1991. Neurochemical action of the general anaesthetic propofol on the chloride ion channel coupled with GABAA receptors. Brain Res. 542:225–232.

    Google Scholar 

  40. Prince, R. J. and Simmonds M. A. 1992. Propofol potentiates the binding of [3H]flunitrazepam to the GABAA receptor complex. Brain Res. 596:238–242.

    Google Scholar 

  41. Orser, B. A., Wang, L.-Y., Pennefather, P. S., and MacDonald, J. F. 1994. Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons. J. Neurosci. 14:7747–7760.

    Google Scholar 

  42. Jones, M. V., Harrison, N. L., Pritchett, D. B., and Hales, T. G. 1995. Modulation of the GABAA receptor by propofol is independent of the γ subunit. J. Pharmacol. Exp. Ther. 24:962–968.

    Google Scholar 

  43. Albertson, T. E., Walby, W. E., Stark, L. G., and Joy, R. M. 1996. The effect of propofol on CA1 pyramidal cell excitability and GABAA-mediated inhibition in the rat hippocampal slice. Life Sci. 58:2397–2407.

    Google Scholar 

  44. Zhong, Y. and Simmonds, M. A. 1996. Phamacological characterisation of multiple components in the enhancement by pregnanolone and propofol of [3H]flunitrazepam binding to GABAA receptors. Neuropharmacol. 35:1193–1198.

    Google Scholar 

  45. O'Shea, S. M., Wong, L. C., and Harrison, N. L. 2000. Propofol increases agonist efficacy at the GABAA receptor. Brain Res. 852:344–348.

    Google Scholar 

  46. Lloyd, K. G., Zivkovic, B., Sanger, D., Depoortere, H., and Bartholini, G. 1987. Fengabine, a novel antidepressant GABA ergic agent. I. activity in models for antidepressant drugs and psychopharmacological profile. J. Pharmacol. Exp. Ther. 241:245–250.

    Google Scholar 

  47. Straub, H., Kohling, R., and Speckmann, E. J. 1994. Picrotoxin-induced epileptic activity in hippocampal and neocortical slices (guinea pig): suppression by organic calcium channel blockers. Brain Res. 658:119–126.

    Google Scholar 

  48. Enna, S. J. and Snyder, S. H. 1977. Influences of ions, enzymes, and detergents on γ-aminobutyric acid-receptor binding in synaptic membranes of rat brain. Mol. Pharmacol. 13:442–453.

    Google Scholar 

  49. Wong, D. T. and Horng, J. S. 1977. Na+-independent binding of GABA to the triton X-100 treated synaptic membranes from cerebellum of rat brain. Life Sci. 20:445–451.

    Google Scholar 

  50. Williams, M. and Risley, E. A. 1979. Characterization of the binding of [3H]muscimol, a potent γ-aminobutyric acid agonist, to rat brain synaptosomal membranes using a filtration assay. J. Neurochem. 32:713–718.

    Google Scholar 

  51. Naik, S. R., Naik, P. R., and Sheth, U. K. 1978. Involvement of γ-amino butyric acid (GABA) in the anticonvulsant action of methaqualone. Psychopharmacol. 57:103–107.

    Google Scholar 

  52. Garrett, K. M. and Gan, J. P. 1998. Enhancement of γ-amino butyric acidA receptor activity by γ-chloralose. J. Pharmacol. Exp. Ther. 285:680–686.

    Google Scholar 

  53. Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., Seeman, P., and Wong, D. T. 1996. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacol. 14:87–96.

    Google Scholar 

  54. Korpi, E. R., Wong, G., and Lü ddens, H. 1995. Subtype specificity of γ-aminobutyric acid type A receptor antagonism by clozapine. Naunyn-Schmiederberg's Arch. Pharmacol. 352:365–373.

    Google Scholar 

  55. Fritschy, J.-M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T. and Mö hler, H. 1992. Five subtypes of type A γ-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc. Natl. Acad. Sci. 89:6726–6730.

    Google Scholar 

  56. Mohler, H., Knoflach, F., Paysan, J., Motejlek, K., Benke, D., Lü scher, B., and Fritschy, J. M. 1995. Heterogeneity of GABAA receptors: cell-specific expression, pharmacology, and regulation. Neurochem. Res. 20:631–636.

    Google Scholar 

  57. McKernan, R. M. and Whiting, P. J. 1996. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 19:139–143.

    Google Scholar 

  58. Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O, and Somogyi, P. 1995. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378:75–78.

    Google Scholar 

  59. Farnbach-Pralong, D., Bradbury, R., Copolov, D., and Dean, B. 1998. Clozapine and olanzapine treatment decreases rat cortical and limbic GABAA receptors. Eur. J. Pharmacol. 349:R7–R8.

    Google Scholar 

  60. Eagles, J. M. 1992. Are polioviruses a cause of schizophrenia? Br. J. Psychiatry 160:598–600.

    Google Scholar 

  61. Squires, R. F. 1997. How a poliovirus might cause schizophrenia: a comment on Engles' hypothesis. Neurochem. Res. 22:647–656.

    Google Scholar 

  62. Suvisaari, J., Haukka, J., Tanskanen, A., Hovi, T., and Lö nnqvist, J. 1999. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am. J. Psychiatry 156:1100–1102.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Neurochemistry, The Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, 10962, U.S.A.

    Richard Felt Squires

  2. Center for Neurochemistry, The Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, 10962, U.S.A

    Else Saederup

Authors
  1. Richard Felt Squires
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Else Saederup
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Short Title: Enhancement of [3H]Muscimol binding|.

Short Title: Enhancement of [3H]Muscimol binding

Rights and permissions

Reprints and permissions

About this article

Cite this article

Felt Squires, R., Saederup, E. Additivities of Compounds that Increase the Numbers of High Affinity [3H]Muscimol Binding Sites by Different Amounts Define More than 9 GABAA Receptor Complexes in Rat Forebrain: Implications for Schizophrenia and Clozapine Research. Neurochem Res 25, 1587–1601 (2000). https://doi.org/10.1023/A:1026666419725

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026666419725

Search

Navigation